A qualitative study of menopause among women with disabilities

Advances in Nursing Science

Volumn 30, Issue 2, 2007, Pages 123-138

  Harrison, Tracie ^a   Becker, Heather ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Feminist methods; Menopause; Qualitative description; Women with disabilities

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; ATTITUDE TO HEALTH; DISABLED PERSON; EMOTION; FEMALE; HUMAN; INTERVIEW; INTUITION; MENOPAUSE; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; SELF CONCEPT; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT;

ADAPTATION, PSYCHOLOGICAL; ADULT; DISABLED PERSONS; EMOTIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS; INTUITION; MENOPAUSE; MIDDLE AGED; QUALITATIVE RESEARCH; SELF CONCEPT; SOCIAL SUPPORT; SOCIAL VALUES;

EID: 34249016457     PISSN: 01619268     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ANS.0000271103.57290.6e     Document Type: Article

References (65)

1. Jans L, Stoddard S. Chartbook on Women and Disability in the United States. Washington, DC: National Institute on Disability and Rehabilitation Research, US Department of Education; 1999.
2. Soules MR, Sherman S, Parrott E, et al. States of reproductive aging workshop. J Womens Health Gend Based Med. 2001;10(9):843-848.
3. Im EO, Chee W. A descriptive Internet survey on menopausal symptoms: five ethnic groups of Asian American university faculty and staff. J Transcult Nurs. 2005;16:126-135.
4. Michel JL, Mahady GB, Valiz M, Soejarto DD, Caceres A. Symptoms, attitudes and treatment choices surrounding menopause among the Q'eqchi Maya of Livingston, Guatemala. Soc Sci Med. 2006;63:732-742.
5. Tucker SJ. The menopause : how much soma and how much psyche? JOGN Nurs. 1977;6(5):40-48.
6. Sandelowski M. What ever happened to qualitative description? Res Nurs Health. 2000;23:334-340.
7. Belensky MF, Clinchy BM, Goldberger NR, Tarule JM. Women's Ways of Knowing. New York: Basic Books; 1997. Originally published, in 1986.
8. Leicester M. Two decades of feminist thought - and beyond. Int J lifelong Educ. 2001;1-2:55-62.
9. Kaye H. Disability Watch - The Status of People With Disabilities in the United States. Volcano, Calif: Volcano Press; 1997.
10. Phillips L, Phillips W. Better reproductive healthcare for women with disabilities: a role for nursing leadership. ANS Adv Nurs Sci. 2006;29(2):134-151.
11. Nosek M, Howland C. Breast and cervical cancer screening among women with physical disabilities. Arch Phys Med Rehabil 1997;78:S39-S44.
12. Coyle C, Santiago M, Shank H, Ma G, Boyd R. Secondary conditions and women with physical disabilities: a descriptive study. Arch Phys Med Rehabil. 2000;81;1380-1387.
13. Coyle C, Santiago M. Healthcare utilization among women with physical disabilities. Medscape General Medicine. 2002. Available at: http://www.medscape.com/viewarticle/433156. Accessed June 5, 2003.
14. Gans B, Mann N, Becker B. Delivery of primary care to the physically challenged. Arch Phys Med Rehabil. 1993;74:S15-S19.
15. Goldberger N, Tarule J, Clinchy B, Belenky M. Knowledge, Difference, and Power New York: Basic Books; 1996.
16. Kelman A, Lane NE. The management of secondary osteoporosis. Best Pract Res Clin Rheumatol. 2005;19(6):1021-1037.
17. Strotmeyer ES, Steenkiste AR, Caluey JA, Dorman J, Orchard TJ. Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than non-diabetic women. Diabetes Care. 2006;29(2):306-311.
18. Derk C. Osteoporosis in premenopause. When are screening and treatment prudent? Postgrad Med. 2006;119(1):8-15.
19. Herzog AG. Menstrual disorders in women with epilepsy. Neurology. 2006;66:S23-S28.
20. Dizon CD, Allen LM, Ornstein ME Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the hospital for sick children, Toronto. J Pediatr Adolesc Gynecol. 2005;18:157-162.
21. Taylor AE. Systemic adversities of ovarian failure. J Soc Gynecol Investig. 2001;8:S7-S9.
22. Carr J, Hollins S. Menopause in women with learning disabilities. J Intellect Disabil Res. 1995;39(pt 2):137-139.
23. Schupf N, Zigman W, Kapell D, Lee JH, Kline J, Levin B. Early menopause in women with Down's syndrome. J Intellect Disabil Res. 1997;41(pt 3):264-267.
24. Seltzer GB, Schupf N, Wu HS. A prospective study of menopause in women with Down's syndrome. J Intellect Disabil Res. 2001;45(pt 1):1-7.
25. Harden C, Koppel B, Herzog A, Nikolov B, Hauser W Seizure frequency is associated with age at menopause in women with epilepsy. Neurology. 2003;61:451-455.
26. Henderson Y The neurology of menopause. Neurologist. 2006;12(3):149-159.
27. Yang XY, Liang LQ, Zhan ZP, Ye YJ. Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Zhongua Yi Xue Zhi. 2005;85:960-962.
28. Jackson A, Wadley V A multicenter study of women's self-reported reproductive health after spinal cord injury. Arch Phys Med Rehabil. 1999;80:1420-1428.
29. Becker H, Stuifbergen A, Gordon D. Menopausal experiences and hormone replacement therapy use among women with physical impairments. Womens Health Issues. 2002;12:212-219.
30. Sowers M, Pope S, Welch G, Sternfeld B, Albrecht G. The association of menopause and physical functioning in women at midlife. J Am Geriatr Soc. 2001;49:1485-1492.
31. Federal Drug Administration. Physician Information. Kalamazoo, Mich: Pharmacia & Upjohn; 2004. Available at: http://www.fda.gov/medwatch/ safety/2004/DepoProvera_Label.pdf. Accessed February 9, 2007.
32. Kelman A, Lane NE. The management of secondary osteoporosis. Best Pract Res Clin Rheumatol. 2005;19(6):1021-1037.
33. Angeli A, Guglielmi G, Dovio A, et al. High prevalence of asymptomatic vertebral fractures in postmenopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone. 2006;39:253-259.
34. Sinigaglia L, Nervetti A, Mela Q, et al. A multi-center cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rhenmatol. 2000;27:2582-2589.
35. Aral K, Hanyu T, Sugitani H, et al. Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. J Bone Miner Metab. 2006;24:118-124.
36. Miller VM Jayachandran M, Heit JA, Owen WG. Estrogen therapy and thrombotic risk. Pharmacol Ther. 2006;111(3):792-807.
37. Kroll HR, Odderson IR, Allen FH. Deep vein thrombi associated with the use of plastic ankle-foot orthoses. Arch Phys Med Rehabil 1998;79:576-578.
38. Smith R, Studd JWW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med. 1992;85:612-613.
39. Holmqvist P, Wallberg M, Hammar M, Landtblom A, Brynhildsen J. Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas. 2006;54:149-153.
40. Kuiper S, van Gestel AM, Swinkels HL, de Boo TM, da Silva JA, van Riel PL. Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. J Rheumatol. 2001;28(8):1809-1816.
41. Welner S, Simon J, Welner B. Maximizing health in menopausal women with disabilities. Menopause. 2002;9(3):208-219.
42. Macfarlane TV Blinkhorn A, Worthington HV Davies R, Macfarlane G. Sex hormonal factors and chronic widespread pain: a population study among women. Rheumatology, 2002;41:454-457.
43. Panuk ON, Cakir N. The variation in chronic widespread pain and other symptoms in flbromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol. 2005;23(6):778-782.
44. Samborski W, Sobieska M, Peita P, Drews K, Brzosko M. Normal profile of sex hormones in women with primary fibromyalgia. Ann Acad Med Stetin. 2005;51(2):23-26.
45. Szoeke CEI, Cicuttini F, Guthrie J, Dennerstein L. Self-reported arthritis and the menopause. Climacteric. 2005;8:49-55.
46. Kapoor D, Thakar R, Sultan A. Combined urinary and faecal incontinence. Int Urogynecol J Pelvic Floor Funct 2005;16:321-328.
47. Jedrzejuk D, Milewicz A. Consequences of menopause in women with diabetes mellitus - a clinical problem. Gynecol Endocrinol. 2005;21(5):280-286.
48. Anderson F, Spencer F. Risk factors for venous thromboembolism. Circulation. 2003;107:19-116.
49. Broholm B, Podenphant J, Biering-Sorensen F The course of bone mineral density and biochemical markers of bone turnover in early postmenopausal spinal cord-lesioned females. Spinal Cord. 2005;43:674-677.
50. Wu O. Postmenopausal hormone replacement therapy and venous thromboembolism. Gend Med. 2005;2:818-827.
51. US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, Md: Office of the Surgeon General, US Department of Health and Human Services: 2004. Available at: http://www.surgeongeneral.gov/library. Accessed October 2, 2006.
52. Kalpakjian CZ, Toussaint LL, Quint EH, Reame NK. Use of a standardized menopause symptom rating scale in a sample of women with physical disabilities. Menopause. 2005;12(1):78-87.
53. Dannels A, Charlifue S. The perimenopause experience for women with spinal cord injuries. SCI Nurs. 2004;21(1):9-13.
54. Becker H, Stuifbergen A, Dormire S. Improving decision-making about hormone therapy among women with mobility impairments. Paper presented at: 16th International Nursing Research Congress; July 15, 2005; Kona, Hawaii.
55. Miles MB, Huberman AM. Qualitative Data Analysis, 2nd ed. Thousand Oaks, Calif: Sage; 1994.
56. Department of Health and Human Services. The women's health initiative. Available at: http://www.nhlbl.nih.gov/whi/background.htm. Accessed October 9, 2006.
57. Schnoberg MA, Davis RB, Wee CC. After the women's health initiative: decision making and trust of women taking hormone therapy. Women's Health Issues, 2005;15:187-195.
58. Walter FM, Emery JD, Rogers M, Britten N. Women's view of optimal risk communication and decision making in general practice consultations about the menopause and hormone replacement therapy. Patient Educ Couns. 2004;53:121-128.
59. Stephens C, Carryer J, Budge C. To have or to take: discourse, positioning, and narrative identity in women's accounts of HRT. Health, 2004;8(3):329-350.
60. Oliver M. Understanding Disability: From Theory to Practice. New York: Thousand Oaks Press; 1996.
61. Marmoeo J, Brown JB, Batty HR, Cummings S, Powell M. Hormone replacement therapy: determinants of women's decisions. Patient Educ Couns. 1998;33:289-298.
62. Nosek M. Overcoming the odds: the health of women with physical disabilities in the United States. Arch Phys Med Rehabil. 2000;81:135-138.
63. Palmlund I. Loyalties in clinical research on drugs: the case of hormone replacement therapy. Soc Sci Med. 2006;63:540-551.
64. Khong S, Savic G, Garnder BP Ashworth E Hormone replacement therapy in women with spinal cord injury - a survey with literature review. Spinal Cord. 2005;43:67-73.
65. Harrison T, Stuifbergen A. Hermeneutic phenomenological study of aging with a childhood onset disability. Health Care Women Int. 2005;26:731-747.